Envestnet (ENV) Peer Comparison

$63.14

$0.05 (0.08%)

As on 22-Nov-2024 19:00EDT

Market cap

$3,495 Mln

Revenue (TTM)

$1,337 Mln

P/E Ratio

--

P/B Ratio

6.6

Div. Yield

0 %

Edit

	Envestnet (ENV)	Trxade Group Inc (MEDS)
Market cap ($ Mln)	3,495	4
Revenue ($ Mln)	1,337	8
Net Profit ($ Mln)	-183,249.35	-88.28
Net Margin (%)	-13,708.02	-1,100.30
RoE (%)	-33,091.46	--
Price to Earnings	--	--
Price-To-Book	6.64	1.81

Income Statement
Liabilities
Assets
Cashflow
Ratios

Income Statement ($ Mln)

	Envestnet (ENV)	Trxade Group Inc (MEDS)
Operating Revenue	1,336.80	0.00
Cost of Revenue	11,540.59	0.00
Gross Profit	327.75	0.00
Operating Expenses	485,794.25	2.88
Operating Profit (EBIT)	-178,683.66	-2.88
Other Income	0.00	--
Profit before Tax	-187,598.56	-2.90
Provision for Tax	-2,582.28	--
Profit after Tax (Net Income)	-183,249.35	-2.90
Minority Interest	3.74	--
Consolidated Profit	0.00	--

Liabilities ($ Mln)

	Envestnet (ENV)	Trxade Group Inc (MEDS)
Shareholder's Funds	526.61	-2.90
Minority Interest	3.74	--
Non-Current Liabilities	684.23	0.35
Current Liabilities	617.86	2.89
Total Liabilities	1,877.25	0.34

Assets ($ Mln)

	Envestnet (ENV)	Trxade Group Inc (MEDS)
Non-Current Assets	1,465.68	0.00
Current Assets	363.02	0.34
Total Assets	1,877.25	0.34
Total Debt*	420.78	0.70
Net Current Assets	-254.84	-2.55

Cashflow ($ Mln)

	Envestnet (ENV)	Trxade Group Inc (MEDS)
Cash From Operating Activities	154.87	-0.35
Cash Flow from Investing Activities	--	--
Cash from Financing Activities	-72.71	0.35
Net Cash Inflow / Outflow	--	--

Ratios

Profitability Ratios

	Envestnet (ENV)	Trxade Group Inc (MEDS)
ROCE (%)	-14.24	262.57
ROE (%)	-33,091.46	199.31
ROA (%)	-7,719.50	-1,711.58
EBIT Margin (%)	-13,900.03	--
Net Margin (%)	-13,708.02	-8.37
Cash Profit Margin (%)	0.00	--

Growth Ratios

	Envestnet (ENV)	Trxade Group Inc (MEDS)
Revenue Growth (%)	9.50	-1.00
EBIT Growth (%)	-355,175.32	--
Net Profit Growth (%)	-196,111.05	-5.54
EPS Growth (%)	-196,922.99	--
Book Value Growth (%)	-29.59	--

Valuation Ratios

	Envestnet (ENV)	Trxade Group Inc (MEDS)
Price / Earnings	-11.34	-1.68
Price / Book Value	4.77	-1.68
Dividend Yield (%)	--	--
EV/EBITDA	-46.51	-1.93
Market Cap ($ Cr)	--	--

Solvency Ratios

	Envestnet (ENV)	Trxade Group Inc (MEDS)
Debt to Equity	1.07	-0.24
Short term debt to equity ratio	0.62	-0.12
Current Ratio	0.59	0.12
Quick Ratio	0.59	0.12
Interest Coverage	-30,828.67	-8.55

Operating Efficiency Ratios

	Envestnet (ENV)	Trxade Group Inc (MEDS)
Debtors to sales (%)	8.24	--
Asset Turnover	0.56	0.00
Receivable days	32.64	10.91
Inventory Days	-10.11	0.76
Payable days	10.56	3.26
Cash Conversion Cycle	11.97	8.41

*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.

Annual
Quarterly